rs774109272
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP2PP3BS2
The ENST00000282516.13(NIPBL):c.5051C>A(p.Thr1684Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000353 in 1,613,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1684I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000282516.13 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPBL | NM_133433.4 | c.5051C>A | p.Thr1684Lys | missense_variant | 26/47 | ENST00000282516.13 | NP_597677.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPBL | ENST00000282516.13 | c.5051C>A | p.Thr1684Lys | missense_variant | 26/47 | 1 | NM_133433.4 | ENSP00000282516 | P1 | |
NIPBL | ENST00000448238.2 | c.5051C>A | p.Thr1684Lys | missense_variant | 26/46 | 1 | ENSP00000406266 | |||
NIPBL | ENST00000652901.1 | c.5051C>A | p.Thr1684Lys | missense_variant | 26/46 | ENSP00000499536 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251150Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135808
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461548Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727096
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74266
ClinVar
Submissions by phenotype
Cornelia de Lange syndrome 1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 21, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 11, 2023 | ClinVar contains an entry for this variant (Variation ID: 1331030). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NIPBL protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with NIPBL-related conditions. This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 1684 of the NIPBL protein (p.Thr1684Lys). This variant is present in population databases (rs774109272, gnomAD 0.004%). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at